Adjustable cerebrospinal fluid shunt valves in 3.0-Tesla MRI: A phantom study using explanted devices

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 182, Issue 7, 2010, Pages 594-602

  Akbar, M ^a   Aschoff, A ^b   Georgi, J C ^a   Nennig, E ^a   Heiland, S ^a   Abel, R ^a   Stippich, C ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

3.0 T MRI; adjustable cerebrospinal fluid shunt valves; Codman Medos valves; failure of adjustability; hydrocephalus

Indexed keywords

ARTICLE; ARTIFACT; CEREBROSPINAL FLUID SHUNTING; CONTROLLED STUDY; HEATING; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PRIORITY JOURNAL; VALVE;

EID: 77953846274     PISSN: 14389029     EISSN: 14389010     Source Type: None    
DOI: 10.1055/s-0028-1109882     Document Type: Article

References (53)

1. Kalousdian S, Karlan M S., Williams M A. Silicone elastomer cerebrospinal fluid shunt systems. Council on Scientific Affairs, American Medical Association. Neurosurgery 1998 42 887-892
2. Medical Data International (3/1996). U. S. markets for neurointerventional, neuroradiology and less-invasive neurosurgery products. #RP 891 234; 1995 2000,. CA, USA Invine
3. Bondurant C P., Jimenez D F. Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 1995 23 254-258
4. Hoglund M, Tisell M, Wikkelso C. Incidence of surgery for hydrocephalus in adults surveyed: same number afflicted by hydrocephalus as by multiple sclerosis. Lakartidningen 2001 98 1681-1685 (Pubitemid 33741433)
5. Del Bigio M R. Epidemiology and direct economic impact of hydrocephalus: a community based study. Can J Neurol Sci 1998 25 123-126
6. Cochrane D D., Kestle J. Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989 2001. Eur J Pediatr Surg 2002 12 S6-S11
7. Patwardhan R V., Nanda A. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005 56 139-144
8. Zemack G, Romner B. Seven years of clinical experience with the programmable Codman Hakim valve: a retrospective analysis of 583 patients. J Neurosurg 2000 92 941-948
9. Miyake H, Ohta T, Kajimoto Y et al. A clinical survey of hydrocephalus and current treatment for hydrocephalus in Japan: analysis by nationwide questionnaire. Childs Nerv Syst 1999 15 363-368
10. Rohde V, Mayfrank L, Ramakers V T. et al. Four-year experience with the routine use of the programmable Hakim valve in the management of children with hydrocephalus. Acta Neurochir 1998 140 1127-1134
11. Vanneste J A. Diagnosis and management of normal-pressure hydrocephalus. J Neurol 2000 247 5-14
12. Joseph P Hornak. The Basic of MRI. Rochester Institute of Technology, Magnetic Resonance Laboratory, Rochester, NY, 1996 2007. Accessed August 18, 2007 http://www.cis.rit.edu/htbook/mri
13. Baudendistel K T., Heverhagen J T., Knopp M V. Klinisches MRT bei 3 Tesla: Aktueller Stand. Radiologe 2004 44 11-18
14. Bernstein M A., Huston 3 rd J, Lin C et al. High-resolution intracranial and cervical MRA at 3.0T: technical considerations and initial experience. Magn Reson Med 2001 46 955-962
15. Campeau N G., Huston 3 rd J, Bernstein M A. et al. Magnetic resonance angiography at 3.0 Tesla: initial clinical experience. Top Magn Reson Imaging 2001 12 183-204
16. Thulborn K R. Clinical rationale for very-high-field (3.0T) functional magnetic resonance imaging. Top Magn Reson Imaging 1999 10 37-50
17. Scarabino T, Nemore F, Giannatempo G M. et al. 3.0T magnetic resonance in neuroradiology. Eur Radiol 2003 48 154-164
18. Regier M, Nolte-Ernsting C, Adam G et al. Intraindividual comparison of image quality in MR urography at 1.5 and 3 tesla in an animal model. Röntgenstr Fortschr 2008 180 915-921
19. Rohr A, Riedel C, Reimann G et al. Pseudotumor cerebri: quantitative in-vivo measurements of markers of intracranial hypertension. Röntgenstr Fortschr 2008 180 884-890, German
20. Horger M, Schulze M, Mroue A et al. Radiologic imaging of primary CNS lymphomas. Röntgenstr Fortschr 2008 180 863-866, German, no abstract available
21. Mönninghoff C, Maderwald S, Theysohn J M. et al. Evaluation of intracranial aneurysms with 7T versus 1.5T time-of-flight MR angiography initial experience. Röntgenstr Fortschr 2009 181 16-23
22. Shellock F G., Crues J V. MR procedures: biologic effects, safety, and patient care. Radiology 2004 232 635-652
23. Schmitt F, Grosu D, Purdy D. 3 Tesla-MRT: Der Erfolg höherer Feldstärken. Radiologe 2004 44 31-48
24. Biller A, Bartsch A, Knaus C et al. Neuroradiologische Diagnostik bei Patienten mit sensorineuralem Hörverlust vor Cochlea-Implantation. Röntgenstr Fortschr 2007 179 901-913
25. Shellock F G., Wilson S F., Mauge C P. Magnetically programmable shunt valve: MRI at 3-Tesla. Magn Reson Imaging 2007 25 1116-121
26. Akbar M, Stippich C, Aschoff A. Magnetic resonance imaging and cerebrospinal fluid shunt valves. N Engl J Med 2005 353 1413-1414
27. Ortler M, Kostron H, Felber S. Transcutaneous pressure-adjustable valves and magnetic resonance imaging: an ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 1997 40 1050-1057
28. Fransen P, Dooms G, Thauvoy C. Safety of the adjustable pressure ventricular valve in magnetic resonance imaging: problems and solutions. Neuroradiology 1992 34 508-509
29. Fransen P. Transcutaneous pressure-adjustable valves and magnetic resonance imaging: an ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 1998 42 430
30. Shellock F G., Habibi R, Knebel J. Programmable CSF Shunt Valve, in vitro assessment of MR imaging safety at 3 T. AJNR Am J Neuroradiol 2006 27 661-665
31. Shellock F G. Reference manual for magnetic resonance safety, implants, and devices. Los Angeles (CA) Biomedical Research Publishing Group 2006
32. Cosman E R. Radiofrequency lesions. Gildenberg PL, Tasker RR Textbook of stereotactic and functional neurosurgery New York McGraw-Hill 1998
33. International standard: neurosurgical implants sterile, single-use hydrocephalus shunts and components. ISO 7197: 1989 (E) TC 150/SC3-N 86. Geneva International Organization of Standardization 1994
34. Standard practice for evaluation and specifying implantable shunt assemblies for neurosurgical application. Proposed revision of standard draft. West Conshohocken, Pa American Society of Testing and Materials 1992
35. Shellock F G., Gounis M, Wakhloo A. Detachable coil for cerebral aneurysms: in vitro evaluation of magnet field interactions, heating, and artifacts at 3-Tesla. AJNR Am J Neuroradiol 2005 26 363-366
36. American Society for Testing and Materials (ASTM) International: F 2182 02. Test method for measurement of radio-frequency induced heating near passive implants during magnetic resonance imaging. Annual Book of ASTM Standards: Medical Devices and Services. Vol. 13.01. West Conshohocken, Pa American Society for Testing and Materials 2003
37. Shellock F G. Thermal responses in human subjects exposed to magnetic resonance imaging. Ann N Y Acad Sci 1992 649 260-272
38. Shellock F G., Schaefer D J., Kanal E. Physiologic responses to an MR imaging procedure performed at a specific absorption rate of 6.0 W/kg. Radiology 1994 192 865-868
39. Rezai A R., Finelli D, Nuenhuis J A. et al. Neurostimulation systems for deep brain stimulation: in vitro evaluation of magnetic resonance imaging-related heating at 1.5 Tesla. J Magn Reson Imaging 2002 15 241-250
40. Bhavaraju N C., Negaraddi V, Chetlapalli S R. et al. Electrical and thermal behaviour of non-ferrous noble metal electrodes exposed to MRI fields. Magn Reson Imaging 2001 20 351-357
41. Georgi J C., Stippich C, Tronnier V M. et al. Active deep brain stimulation during MRI: a feasibility study. Magn Reson Med 2004 51 380-388
42. Shellock F G., Begnaud J, Inman D M. VNS Therapy System: in vitro evaluation of MRI-related heating and function at 1.5-and 3.0-Tesla. Neuromodulation 2006 9 204-213
43. American Society for Testing and Materials (ASTM) International: F 2052. Standard test method for measurement of magnetically induced displacement force on passive implants in the magnetic resonance environment. In: Annual Book of ASTM Standards: Medical Devices and Services. Vol. 13.01. West Conshohocken, Pa American Society for Testing and Materials 2001
44. Sommer T, Maintz D, Schmiedel A et al. Hochfeld- Magnetresonanztomographie: Magnetische Anziehungs-und Rotationskräfte auf metallische Implantate bei 3,0T. Röntgenstr Fortschr 2004 176 731-738
45. Anderson R C., Walker M L., Viner J M. Adjustment and malfunction of programmable valve after exposure to toy magnets. J Neurosurg 2004 101 222-225
46. Miwa K, Kondo H, Sakai N. Pressure changes observed in Codman-Medos programmable valves following magnetic exposure and filliping. Childs Nerv Syst 2001 17 150-153
47. Mauge C, Lilienfeld S. Magnetic resonance imaging and cerebrospinal fluid valves. N Engl J Med 2006 354 531-532, author reply 531 532
48. Lindner D, Preul C, Trantakis C. Effect of 3T MRI on the function of shunt valves-Evaluation of Paedi GAV, Dual Switch and proGAV. Eur J Radiol 2005 56 56-59
49. Mauer U M., Schuler J, Kunz U. The hakim programmable valve: reasons for reprogramming failures. J Neurosurg 2007 107 788-791
50. Kurosaki K, Hamada H, Hayashi N et al. A rare case of shunt malfunction attributable to blockage of a Codman-Hakim programmable shunt valve. Childs Nerv Syst 2002 18 183-185
51. Inoue T, Kuzu Y, Ogasawara K et al. Effect of 3-tesla magnetic resonance imaging on various programmable shunt valves. J Neurosurg 2005 103 163-165
52. Aschoff A, Kremer P, Benesch C. Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices. Childs Nerv Syst 1995 11 193-202
53. Ludemann W, Rosahl S K., Kaminsky J et al. Reliability of a new adjustable shunt device without the need for readjustment following 3-Tesla MRI. Childs Nerv Syst 2005 21 227-229